Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non–Small-Cell Lung Cancer: The JIPANG Study Protocol-Reference-Cited by-同舟云学术

Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non–Small-Cell Lung Cancer: The JIPANG Study Protocol

Published:2018-01 Issue:1 Volume:19 Page:e1-e3
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Yamamoto Nobuyuki,Kenmotsu Hirotsugu^ORCID,Yamanaka Takeharu,Nakamura Shinichiro^ORCID,Tsuboi Masahiro

Funder

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference14 articles.

1. Cisplatin-based adjuvant chemotherapy in patients with completely resected non–small-cell lung cancer;Arriagada;N Engl J Med,2004

2. Vinorelbine plus cisplatin vs. observation in resected non–small-cell lung cancer;Winton;N Engl J Med,2005

3. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non–small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial;Douillard;Lancet Oncol,2006

4. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

5. Adjuvant cisplatin and vinorelbine for completely resected non–small-cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation;Douillard;J Thorac Oncol,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-Based Discovery of Potential HPV E6 and EBNA1 Inhibitors: Implications for Cervical Cancer Treatment;Computation;2024-05-31

2. Prognostic Significance of Tumor Mutation Burden among Patients with Non-small Cell Lung Cancer Who Received Platinum-based Adjuvant Chemotherapy: An Exploratory Study;Journal of Cancer Prevention;2023-12-30

3. Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non–Small-Cell Lung Cancer;Journal of Clinical Oncology;2023-12-01

4. Predictive markers based on transcriptome modules for vinorelbine-based adjuvant chemotherapy for lung adenocarcinoma patients;Lung Cancer;2021-08

5. Les traitements périopératoires des cancers bronchiques non à petites cellules : quelles options en 2020 ?;Revue des Maladies Respiratoires;2021-01